103 related articles for article (PubMed ID: 33813415)
21. Melanoma prognosis in the United States: Identifying barriers for improved care.
Hopkins ZH; Moreno C; Carlisle R; Secrest AM
J Am Acad Dermatol; 2019 May; 80(5):1256-1262. PubMed ID: 30659870
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy Treatment Disparities: A Texas Cancer Registry Analysis of Patients with Cutaneous Melanoma.
Ramirez F; Alvarado L; Dwivedi A; Chacon J
J Immigr Minor Health; 2024 Feb; 26(1):23-33. PubMed ID: 37615821
[TBL] [Abstract][Full Text] [Related]
23. Melanoma Reporting Practices of United States Dermatologists.
Svoboda RM; Glazer AM; Farberg AS; Cowdrey MCE; Rigel DS
Dermatol Surg; 2018 Nov; 44(11):1391-1395. PubMed ID: 29847335
[TBL] [Abstract][Full Text] [Related]
24. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
25. Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS).
Harries M; Mohr P; Grange F; Ehness R; Benjamin L; Siakpere O; Barth J; Stapelkamp C; Pfersch S; McLeod L; Wolowacz S; Kaye JA; Kontoudis I
Int J Clin Pract; 2017 May; 71(5):. PubMed ID: 28508460
[TBL] [Abstract][Full Text] [Related]
26. Practice Patterns and Prognostic Value of Sentinel Lymph Node Biopsy for Thick Melanoma: A National Cancer Database Study.
Song Y; Azari FS; Metzger DA; Fraker DL; Karakousis GC
Ann Surg Oncol; 2019 Dec; 26(13):4651-4662. PubMed ID: 31485823
[TBL] [Abstract][Full Text] [Related]
27. National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma.
Huayllani MT; Restrepo DJ; Boczar D; Avila FR; Bagaria SP; Spaulding AC; Rinker BD; Forte AJ
Anticancer Res; 2020 Jun; 40(6):3411-3415. PubMed ID: 32487638
[TBL] [Abstract][Full Text] [Related]
28. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
[TBL] [Abstract][Full Text] [Related]
29. Inverse association for diagnosis of Alzheimer's disease subsequent to both melanoma and non-melanoma skin cancers in a large, urban, single-centre, Midwestern US patient population.
Ibler E; Tran G; Orrell KA; Serrano L; Majewski S; Sable KA; Thiede R; Laumann AE; West DP; Nardone B
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1893-1896. PubMed ID: 29573497
[TBL] [Abstract][Full Text] [Related]
30. Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study.
Hanna AN; Sinnamon AJ; Roses RE; Kelz RR; Elder DE; Xu X; Pockaj BA; Zager JS; Fraker DL; Karakousis GC
J Am Acad Dermatol; 2019 Feb; 80(2):433-440. PubMed ID: 30165160
[TBL] [Abstract][Full Text] [Related]
31. Analysis of Melanoma in African American Patients in the United States.
Boczar D; Restrepo DJ; Sisti A; Huayllani MT; Saleem HY; Lu X; Cinotto G; Manrique OJ; Spaulding AC; Forte AJ
Anticancer Res; 2019 Nov; 39(11):6333-6337. PubMed ID: 31704864
[TBL] [Abstract][Full Text] [Related]
32. Age-Specific Incidence of Melanoma in the United States.
Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
[TBL] [Abstract][Full Text] [Related]
33. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
[TBL] [Abstract][Full Text] [Related]
34. A review of evidence-based treatment of stage IIB to stage IV melanoma.
Eapen S; Dutcher JP
Cancer Invest; 2005; 23(4):323-37. PubMed ID: 16100945
[No Abstract] [Full Text] [Related]
35. Current treatment of cutaneous melanoma and the sentinel lymph node.
Bruns SD; McGee JM; Phillips JW
J Okla State Med Assoc; 2002 May; 95(5):332-5. PubMed ID: 12043108
[No Abstract] [Full Text] [Related]
36. Melanoma: epidemiology, diagnosis, treatment, and outcomes.
Tuong W; Cheng LS; Armstrong AW
Dermatol Clin; 2012 Jan; 30(1):113-24, ix. PubMed ID: 22117873
[TBL] [Abstract][Full Text] [Related]
37. Disparities in Time to Treatment for Skin Cancer.
Ahmed SH; Manaise HK; Popp R; Sharan S; Bansal S; Sukniam KB; Raikot SR; Kowkabany G; Jimenez PB; Popp K; Mubarak F; George A; Gabriel E
Anticancer Res; 2023 Dec; 43(12):5555-5562. PubMed ID: 38030200
[TBL] [Abstract][Full Text] [Related]
38. Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.
Atkins M; Coutinho AD; Nunna S; Gupte-Singh K; Eaddy M
J Med Econ; 2018 Feb; 21(2):212-217. PubMed ID: 29022427
[TBL] [Abstract][Full Text] [Related]
39. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study.
Feigelson HS; Powers JD; Kumar M; Carroll NM; Pathy A; Ritzwoller DP
Cancer Med; 2019 Aug; 8(9):4508-4516. PubMed ID: 31215776
[TBL] [Abstract][Full Text] [Related]
40. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
